Nephros (NEPH) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 16, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 15, 2025.

Voting matters and shareholder proposals

• Election of Lisa Nettis as Class II Director to serve until the 2028 Annual Meeting.

• Ratification of Baker Tilly US, LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.

• Advisory (non-binding) approval of named executive officer compensation (say-on-pay).

• Proxies may vote on other matters that arise during the meeting or any adjournment.

Board of directors and corporate governance

• Lisa Nettis nominated for election as Class II Director, with term expiring at the 2028 Annual Meeting.